401 related articles for article (PubMed ID: 2415680)
1. Interactions between vasoactive intestinal peptide and dopamine in the rabbit retina: stimulation of a common adenylate cyclase.
Pachter JA; Lam DM
J Neurochem; 1986 Jan; 46(1):257-64. PubMed ID: 2415680
[TBL] [Abstract][Full Text] [Related]
2. The effect of vasoactive intestinal polypeptide (VIP) on forskolin stimulated adenylate cyclase in the caudate-putamen of the rat.
Moser A; Drescher S
Exp Brain Res; 1990; 79(2):383-7. PubMed ID: 2323384
[TBL] [Abstract][Full Text] [Related]
3. Effects of vasoactive intestinal peptide and other peptides on cyclic AMP accumulation in intact pieces and isolated horizontal cells of the teleost retina.
Watling KJ; Dowling JE
J Neurochem; 1983 Nov; 41(5):1205-13. PubMed ID: 6194261
[TBL] [Abstract][Full Text] [Related]
4. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
5. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide receptors linked to an adenylate cyclase, and their relationship with biogenic amine- and somatostatin-sensitive adenylate cyclases on central neuronal and glial cells in primary cultures.
Chneiweiss H; Glowinski J; Prémont J
J Neurochem; 1985 Mar; 44(3):779-86. PubMed ID: 2857767
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides modulate adenylate cyclase activity in rat brain slices: evidence for an ACTH/MSH receptor-coupled mechanism.
Florijn WJ; Mulder AH; Versteeg DH; Gispen WH
J Neurochem; 1993 Jun; 60(6):2204-11. PubMed ID: 8388034
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.
Onali P; Schwartz JP; Costa E
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6531-4. PubMed ID: 6171819
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
10. Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: II. Effects of high potassium, adenylate cyclase activators, and N-n-propyl-3-(3-hydroxyphenyl) piperidine.
Ofori S; Magistretti PJ; Schorderet M
J Neurochem; 1986 Oct; 47(4):1207-13. PubMed ID: 2875130
[TBL] [Abstract][Full Text] [Related]
11. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-dependent cyclic AMP generating system in chick retina and its relation to melatonin biosynthesis.
Zawilska JB; Derbiszewska T; Sek B; Nowak JZ
Neurochem Int; 1995 Dec; 27(6):535-43. PubMed ID: 8574183
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
Longshore MA; Makman MH
Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium.
Bacic F; Uematsu S; McCarron RM; Spatz M
J Neurochem; 1991 Nov; 57(5):1774-80. PubMed ID: 1681036
[TBL] [Abstract][Full Text] [Related]
16. Isolated neuronal growth cones from developing rat forebrain possess adenylate cyclase activity which can be augmented by various receptor agonists.
Lockerbie RO; Hervé D; Blanc G; Tassin JP; Glowinski J
Brain Res; 1988 Jan; 466(1):19-25. PubMed ID: 2829998
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
18. Effects of GTP, forskolin, sodium fluoride, serotonin, dopamine, and carbachol on adenylate cyclase in Teleost retina.
Osborne NN
Neurochem Res; 1990 May; 15(5):523-8. PubMed ID: 1695328
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro.
Griffiths NM; Simmons NL
J Physiol; 1987 Jun; 387():1-17. PubMed ID: 3656172
[TBL] [Abstract][Full Text] [Related]
20. Phorbol esters induce two distinct changes in GH3 pituitary cell adenylate cyclase activity.
Summers ST; Cronin MJ
Arch Biochem Biophys; 1988 Apr; 262(1):12-8. PubMed ID: 2833167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
